Lyssaviruses and rabies: Current conundrums, concerns, contradictions and controversies

F1000Research

Volumn 6, Issue , 2017, Pages

  Rupprecht, Charles ^a   Kuzmin, Ivan ^b   Meslin, Francois ^c  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Lyssaviruses; Rabies; Rabies vaccine; Zoonoses

Indexed keywords

RABIES VACCINE;

ANIMAL CULLING; BADGER; BAT; CANIDAE; CASE FATALITY RATE; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; FERRET; HOST; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; LABORATORY TEST; MASS IMMUNIZATION; MONGOOSE; NEGLECTED DISEASE; NONHUMAN; PHYLOGENY; POPULATION ABUNDANCE; PROGENY; RABIES; RABIES VIRUS; RACCOON; REVIEW; SKUNK; SPECIES DISTRIBUTION; SPECIES EXTINCTION; TAXONOMY; VACCINE PRODUCTION; VIRAL CLEARANCE; VIRUS CARRIER; VIRUS CHARACTERIZATION; VIRUS CLASSIFICATION;

EID: 85015256909     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.10416.1     Document Type: Review

References (115)

1. Walker PJ Firth C Widen SG : Evolution of genome size and complexity in the rhabdoviridae. PLoS Pathog. 2015;11(2):e1004664. 25679389 10.1371/journal.ppat.1004664 4334499 F1000 Recommendation
2. Afonso CL Amarasinghe GK Bányai K : Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351-60. 27216929 10.1007/s00705-016-2880-1 4947412
3. Van Regenmortel MH Burke DS Calisher CH : A proposal to change existing virus species names to non-Latinized binomials. Arch Virol. 2010;155(11):1909-19. 20953644 10.1007/s00705-010-0831-9
4. Van Regenmortel MH Ackermann HW Calisher CH : Virus species polemics: 14 senior virologists oppose a proposed change to the ICTV definition of virus species. Arch Virol. 2013;158(5):1115-9. 23269443 10.1007/s00705-012-1583-5
5. Aréchiga Ceballos N Vázquez Morón S Berciano JM : Novel lyssavirus in bat, Spain. Emerg Infect Dis. 2013;19(5):793-5. 23648051 10.3201/eid1905.121071 3647500
6. Gunawardena PS Marston DA Ellis RJ : Lyssavirus in Indian Flying Foxes, Sri Lanka. Emerg Infect Dis. 2016;22(88):1456-9. 27434858 10.3201/eid2208.151986 4982157 F1000 Recommendation
7. Badrane H Bahloul C Perrin P : Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol. 2001;75(7):3268-76. 11238853 10.1128/JVI.75.7.3268-3276.2001 114120
8. Horton DL Banyard AC Marston DA : Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus. J Gen Virol. 2014;95(Pt 5):1025-32. 24496827 10.1099/vir.0.061952-0 3983756
9. Dietzgen RG Calisher CH Kurath G : Family Rhabdoviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EL, editors. Virus Taxonomy: 9th report of the International Committee on Taxonomy of Viruses. Oxford, UK: Elsevier;2011;686-714. 10.1016/B978-0-12-384684-6.00057-4
10. World Health Organization: Expert consultation on rabies. Second report. WHO Technical Report Series; no. 982. Geneva, Switzerland: World Health Organization;2013;7. Reference Source
11. Kgaladi J Wright N Coertse J : Diversity and epidemiology of Mokola virus. PLoS Negl Trop Dis. 2013 ;7(10):e2511. 24205423 10.1371/journal.pntd.0002511 3812115
12. Badrane H Tordo N : Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. J Virol. 2001;75(17):8096-104. 11483755 10.1128/JVI.75.17.8096-8104.2001 115054
13. Davis PL Bourhy H Holmes EC : The evolutionary history and dynamics of bat rabies virus. Infect Genet Evol. 2006;6(6):464-73. 16621724 10.1016/j.meegid.2006.02.007
14. Woelk CH Holmes EC : Reduced positive selection in vector-borne RNA viruses. Mol Biol Evol. 2002;19(12):2333-6. 12446826 10.1093/oxfordjournals.molbev.a004059
15. Kuzmina NA Kuzmin IV Ellison JA : A reassessment of the evolutionary timescale of bat rabies viruses based upon glycoprotein gene sequences. Virus Genes. 2013;47(2):305-10. 23839669 10.1007/s11262-013-0952-9
16. Streicker DG Altizer SM Velasco-Villa A : Variable evolutionary routes to host establishment across repeated rabies virus host shifts among bats. Proc Natl Acad Sci U S A. 2012;109(48):19715-20. 23150575 10.1073/pnas.1203456109
17. Markotter W Randles J Rupprecht CE : Lagos bat virus, South Africa. Emerg Infect Dis. 2006;12(3):504-6. 16704795 3291461
18. Kuzmin IV Niezgoda M Franka R : Lagos bat virus in Kenya. J Clin Microbiol. 2008;46(4):1451-61. 18305130 10.1128/JCM.00016-08 2292963
19. Streicker DG Turmelle AS Vonhof MJ : Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science. 2010;329(5992):676-9. 20689015 10.1126/science.1188836
20. Kuzmin IV Shi M Orciari LA : Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009. PLoS Pathog. 2012;8(6):e1002786. 22737076 10.1371/journal.ppat.1002786
21. Hughes GJ Orciari LA Rupprecht CE : Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J Gen Virol. 2005;86(Pt 5):1467-74. 15831959 10.1099/vir.0.80710-0
22. Nadin-Davis SA Feng Y Mousse D : Spatial and temporal dynamics of rabies virus variants in big brown bat populations across Canada: footprints of an emerging zoonosis. Mol Ecol. 2010;19(10):2120-36. 20406385 10.1111/j.1365-294X.2010.04630.x
23. Wertheim JO Kosakovsky Pond SL : Purifying selection can obscure the ancient age of viral lineages. Mol Biol Evol. 2011;28(12):3355-65. 21705379 10.1093/molbev/msr170 3247791 F1000 Recommendation
24. Wertheim JO Chu DK Peiris JS : A case for the ancient origin of coronaviruses. J Virol. 2013;87(12):7039-45. 23596293 10.1128/JVI.03273-12 3676139
25. Duchêne S Duchêne D Holmes EC : The Performance of the Date-Randomization Test in Phylogenetic Analyses of Time-Structured Virus Data. Mol Biol Evol. 2015;32(7):1895-906. 25771196 10.1093/molbev/msv056
26. Ho SY Lanfear R Bromham L : Time-dependent rates of molecular evolution. Mol Ecol. 2011;20(15):3087-101. 21740474 10.1111/j.1365-294X.2011.05178.x
27. Holmes EC : Complexities of Estimating Evolutionary Rates in Viruses. J Virol. 2016;90(4):2155. 26822594 10.1128/JVI.02570-15 4734009
28. Rupprecht CE Turmelle A Kuzmin IV : A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol. 2011;1(6):662-70. 22440925 10.1016/j.coviro.2011.10.014
29. Nadin-Davis SA Real LA : Molecular phylogenetics of the lyssaviruses--insights from a coalescent approach. Adv Virus Res. 2011;79:203-38. 21601049 10.1016/B978-0-12-387040-7.00011-1
30. Kuzmin IV Tordo N : Genus Lyssavirus. In: Dietzgen RD, Kuzmin IV, editors. Rhabdoviruses: Molecular taxonomy, evolution, genomics, ecology, host-vector interactions, cytopathology and control. London, UK: Caister Academic Press;2012;37-57. Reference Source
31. Eick GN Jacobs DS Matthee CA : A nuclear DNA phylogenetic perspective on the evolution of echolocation and historical biogeography of extant bats (chiroptera). Mol Biol Evol. 2005;22(9):1869-86. 15930153 10.1093/molbev/msi180
32. Simmons NB Seymour KL Habersetzer J : Primitive Early Eocene bat from Wyoming and the evolution of flight and echolocation. Nature. 2008;451(7180):818-21. 18270539 10.1038/nature06549
33. Arnason U Adegoke JA Gullberg A : Mitogenomic relationships of placental mammals and molecular estimates of their divergences. Gene. 2008;421(1-2):37-51. 18590805 10.1016/j.gene.2008.05.024
34. Raup DM Sepkoski JJ Jr : Mass extinctions in the marine fossil record. Science. 1982;215(4539):1501-3. 17788674 10.1126/science.215.4539.1501
35. Aiewsakun P Katzourakis A : Endogenous viruses: Connecting recent and ancient viral evolution. Virology. 2015;479-480:26-37. 25771486 10.1016/j.virol.2015.02.011
36. Chaves LB Achkar SM Silva Ade C : Monoclonal antibodies for characterization of rabies virus isolated from non-hematophagous bats in Brazil. J Infect Dev Ctries. 2015;9(11):1238-49. 26623633 10.3855/jidc.6959 F1000 Recommendation
37. OIE: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2016, chapter 2.1.17 rabies. (accessed 10/26/2016). Reference Source
38. Mallewa M Vallely P Faragher B : Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study. Lancet Glob Health. 2013;1(3):e153-60. 24748325 10.1016/S2214-109X(13)70060-3 3986031
39. Dato VM Campagnolo ER Long J : A Systematic Review of Human Bat Rabies Virus Variant Cases: Evaluating Unprotected Physical Contact with Claws and Teeth in Support of Accurate Risk Assessments. PLoS One. 2016;11(7):e0159443. 27459720 10.1371/journal.pone.0159443 4961291
40. Boland TA McGuone D Jindal J : Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies. Ann Neurol. 2014;75(1):155-60. 24038455 10.1002/ana.24016 4118733
41. Savadogo M Boushab MB : [Rabies in children: an often unknown risk among populations at risk]. Med Sante Trop. 2015;25(2):222-4. 26039715 10.1684/mst.2015.0449
42. Zhou H Zhu W Zeng J : Probable Rabies Virus Transmission through Organ Transplantation, China, 2015. Emerg Infect Dis. 2016;22(8):1348-52. 27331337 10.3201/eid2208.151993 4982156 F1000 Recommendation
43. Chang SS Tsai HJ Chang FY : Government Response to the Discovery of a Rabies Virus Reservoir Species on a Previously Designated Rabies-Free Island, Taiwan, 1999-2014. Zoonoses Public Health. 2016;63(5):396-402. 26542085 10.1111/zph.12240 F1000 Recommendation
44. Sinclair JR Wallace RM Gruszynski K : Rabies in a Dog Imported from Egypt with a Falsified Rabies Vaccination Certificate--Virginia, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(49):1359-62. 26678293 10.15585/mmwr.mm6449a2 F1000 Recommendation
45. Rupprecht CE Nagarajan T Ertl H : Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention. Expert Rev Vaccines. 2016;15(6):731-49. 26796599 10.1586/14760584.2016.1140040
46. Giesen A Gniel D Malerczyk C : 30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience. Expert Rev Vaccines. 2015;14(3):351-67. 25683583 10.1586/14760584.2015.1011134 F1000 Recommendation
47. Pichon S Guinet-Morlot F Minutello M : A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial. Vaccine. 2013;31(18):2295-301. 23510665 10.1016/j.vaccine.2013.02.058
48. Rupprecht CE Briggs D Brown CM : Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2010;59(RR-2):1-9. 20300058
49. Bharti OK Madhusudana SN Gaunta PL : Local infiltration of rabies immunoglobulins without systemic intramuscular administration: An alternative cost effective approach for passive immunization against rabies. Hum Vaccin Immunother. 2016;12(3):837-42. 26317441 10.1080/21645515.2015.1085142 4964710 F1000 Recommendation
50. Bose A Munshi R Tripathy RM : A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes. Vaccine. 2016;34(40):4820-6. 27554534 10.1016/j.vaccine.2016.08.005
51. De Benedictis P Minola A Rota Nodari E : Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol Med. 2016;8(4):407-21. 26992832 10.15252/emmm.201505986 4818751 F1000 Recommendation
52. Madhusudana SN Ashwin BY Sudarshan S : Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies. Hum Vaccin Immunother. 2013;9(9):1914-7. 23792347 10.4161/hv.25431 3906356
53. Morimoto K Khawplod P Sato Y : Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin. Arch Virol. 2016;161(9):2537-41. 27270361 10.1007/s00705-016-2916-6
54. Ren J Yao L Sun J : Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination. Clin Vaccine Immunol. 2015;22(1):1-5. 25392012 10.1128/CVI.00531-14 4278924
55. Reveneau E Cottin P Rasuli A : Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab') 2 fragments. Expert Rev Vaccines. 2016;1-15. 27809689 10.1080/14760584.2017.1244009
56. Wilde H Lumlertdacha B Meslin FX : Worldwide rabies deaths prevention--A focus on the current inadequacies in postexposure prophylaxis of animal bite victims. Vaccine. 2016;34(2):187-9. 26626211 10.1016/j.vaccine.2015.11.036
57. Wongsaroj P Udomchaisakul P Tepsumethanon S : Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Vaccine. 2013;31(13):1748-51. 23370149 10.1016/j.vaccine.2013.01.035
58. Zhang Y Zhang S Li L : Ineffectiveness of rabies vaccination alone for post-exposure protection against rabies infection in animal models. Antiviral Res. 2016;135:56-61. 27737787 10.1016/j.antiviral.2016.10.002
59. Warrell MJ : The dilemma of managing human rabies encephalitis. Trop Med Int Health. 2016;21(4):456-7. 26799263 10.1111/tmi.12668
60. Appolinario CM Jackson AC : Antiviral therapy for human rabies. Antivir Ther. 2015;20(1):1-10. 25156675 10.3851/IMP2851
61. Willoughby RE Jr Tieves KS Hoffman GM : Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508-14. 15958806 10.1056/NEJMoa050382 F1000 Recommendation
62. Zeiler FA Jackson AC : Critical Appraisal of the Milwaukee Protocol for Rabies: This Failed Approach Should Be Abandoned. Can J Neurol Sci. 2016;43(1):44-51. 26639059 10.1017/cjn.2015.331
63. Manoj S Mukherjee A Johri S : Recovery from rabies, a universally fatal disease. Mil Med Res. 2016;3:21. 27429788 10.1186/s40779-016-0089-y 4947331
64. Mahadevan A Suja MS Mani RS : Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis. Neurotherapeutics. 2016;13(3):477-92. 27324391 10.1007/s13311-016-0452-4 4965414
65. Pan American Health Organization: Elimination of dog-transmitted human rabies is by 2015 within reach. PAHO,2013; (accessed 09/27/2016). Reference Source
66. World Health Organization: Sustaining the drive to overcome the global impact of neglected tropical diseases, second report on neglected tropical diseases. World Health Organization, Geneva,2012. Reference Source
67. World Health Organization: Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Executive summary. World Health Organization. Geneva,2012. Reference Source
68. World Health Organization: Global elimination of dog-mediated human rabies. Report of the Global Conference, 10-11 December 2015. World Health Organization and World Animal Health Organization,2016. WHO_HTM_NTD_NZD_ 2016.02. Reference Source
69. World Health Organization: Resolution WHA66.12 on NTD adopted by the World Health Assembly on 27 May 2013. (accessed 10/12/2016). Reference Source
70. Hampson K Coudeville L Lembo T : Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709. 25881058 10.1371/journal.pntd.0003709 4400070
71. Dehove A : OIE regional vaccine banks. Presentation made to the Middle East & Eastern Europe Rabies Expert Bureau Meeting (MEEREB)7-9 April 2015, Lyon, France; (accessed 09/27/2016). Reference Source
72. OIE: Regional Vaccine Bank for Asia provides 50,000 rabies vaccine doses to Lao PDR. OIE Press releases, 28 September 2012; (accessed 09/27/2016). Reference Source
73. Abela-Ridder B Martin S Gongal G : Rabies vaccine stockpile: fixing the supply chain. Bull World Health Organ. 2016;94(9):635-635A. 27708465 10.2471/BLT.16.183012 5034646
74. World Health Organization: Human and dog rabies vaccines and immunoglobulins report of a WHO/OIE meeting. Geneva 12-13 October 2015. WHO/HTM/NTD/NZD/2015.11. Reference Source
75. CDC: Compendium of animal rabies prevention and control. NASPHV Recommendations and Report, MMWR.2011;60(6):1-14. Reference Source
76. Schneider MC Belotto A Adé MP : Current status of human rabies transmitted by dogs in Latin America. Cad Saude Publica. 2007;23(9):2049-63. 17700940 10.1590/S0102-311X2007000900013
77. Vigilato MA Clavijo A Knobl T : Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623):20120143. 23798691 10.1098/rstb.2012.0143 3720041
78. World Health Organization: Vaccine standards.2016; (accessed 10/26/2016). Reference Source
79. Partners For Rabies Prevention: Human:dog ratios obtained from detailed studies in a range of rural and urban settings. In Canines rabies blueprint. (accessed 10/06/2016). Reference Source
80. Knobel DL Cleaveland S Coleman PG : Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005;83(5):360-8. 15976877 2626230
81. Sudarshan MK Madhusudana SN Mahendra BJ : Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis. 2007;11(1):29-35. 16678463 10.1016/j.ijid.2005.10.007
82. Bögel K Meslin FX : Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ. 1990;68(3):281-91. 2118428 2393068
83. FAO: Developing a stepwise approach for rabies prevention and control. FAO/GARC workshop. FAO Animal Production and Health Proceedings, No 18, Rome, Italy. Reference Source
84. Partners For Rabies Prevention: Blueprint for dog rabies control. (accessed 10/06/2016). Reference Source
85. World Health Organization: Report of the 4th meeting of the international coordination group of the Gates Foundation/WHO project for human and dog rabies elimination in low-income countries. 19-21 October 2011, PieterMartizburg, KwaZuluNatal, South Africa. Geneva, World Health Organization,2011; (accessed 10/06/2016). Reference Source
86. Zinsstag J Dürr S Penny MA : Transmission dynamics and economics of rabies control in dogs and humans in an African city. Proc Natl Acad Sci U S A. 2009;106(35):14996-5001. 19706492 10.1073/pnas.0904740106 2728111
87. World Health Organization: Educate, vaccinate, eliminate: Achieving zero human deaths from dog- transmitted rabies by 2030. Joint Statement World Health Organization (WHO), World Organisation for Animal Health (OIE), Food and Agriculture Organization of the United Nations (FAO), 28 September 2016 | Geneva; (accessed 10/26/2016). Reference Source
88. NCDC: National Rabies Prevention & Control Pilot Projects in Ahmedabad, Bangalore, Pune, Madurai and Delhi under the 11th five year plan [2007 - 2012] and National Rabies Control Programme under the 12th five year plan (2012-17). Zoonoses Section, National Centre for Disease Control (NCDC), Delhi, India.
89. Molloy A : China to crackdown on pet dogs. (accessed 10/13/2016). Reference Source
90. Müller T Dietzschold B Ertl H : Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis. 2009;3(11):e542. 19888334 10.1371/journal.pntd.0000542 2765635
91. Halstead SB : Vaccines are forever. A short history of the Rockefeller Foundation/WHO Rabies Vaccine Production Technology Transfer Project. Presented at the occasion of the inauguration of VECOL rabies vaccine production unit, Bogota, Columbia. 1/25/2002; (accessed 1/23/2017). Reference Source
92. Fitzpatrick MC Shah HA Pandey A : One Health approach to cost-effective rabies control in India. Proc Natl Acad Sci U S A. 2016;113(51):14574-81. 27994161 10.1073/pnas.1604975113 5187709 F1000 Recommendation
93. Hamilton PB Teixeira MM Stevens JR : The evolution of Trypanosoma cruzi: the 'bat seeding' hypothesis. Trends Parasitol. 2012;28(4):136-41. 22365905 10.1016/j.pt.2012.01.006
94. Mani RS Anand AM Madhusudana SN : Human rabies in India: an audit from a rabies diagnostic laboratory. Trop Med Int Health. 2016;21(4):556-63. 26799375 10.1111/tmi.12669 F1000 Recommendation
95. Madhusudana SN Subha S Thankappan U : Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans. Virol Sin. 2012;27(5):299-302. 23055005 10.1007/s12250-012-3265-6
96. Carrieri ML Peixoto ZM Paciencia ML : Laboratory diagnosis of equine rabies and its implications for human postexposure prophylaxis. J Virol Methods. 2006;138(1-2):1-9. 16919789 10.1016/j.jviromet.2006.07.005
97. Léchenne M Naïssengar K Lepelletier A : Validation of a Rapid Rabies Diagnostic Tool for Field Surveillance in Developing Countries. PLoS Negl Trop Dis. 2016;10(10):e0005010. 27706156 10.1371/journal.pntd.0005010 5051951 F1000 Recommendation
98. Eggerbauer E de Benedictis P Hoffmann B : Evaluation of Six Commercially Available Rapid Immunochromatographic Tests for the Diagnosis of Rabies in Brain Material. PLoS Negl Trop Dis. 2016;10(6):e0004776. 27336943 10.1371/journal.pntd.0004776 4918935 F1000 Recommendation
99. Ngoepe E Fehlner-Gardiner C Wandeler A : Antigenic characterisation of lyssaviruses in South Africa. Onderstepoort J Vet Res. 2014;81(1). 25685866 10.4102/ojvr.v81i1.711
100. Pratt PD Henschel K Turabelidze G : Human Rabies - Missouri, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(10):253-6. 26985578 10.15585/mmwr.mm6510a1
101. Dacheux L Larrous F Lavenir R : Dual Combined Real-Time Reverse Transcription Polymerase Chain Reaction Assay for the Diagnosis of Lyssavirus Infection. PLoS Negl Trop Dis. 2016;10(7):e0004812. 27380028 10.1371/journal.pntd.0004812 4933377 F1000 Recommendation
102. Wasniewski M Almeida I Baur A : First international collaborative study to evaluate rabies antibody detection method for use in monitoring the effectiveness of oral vaccination programmes in fox and raccoon dog in Europe. J Virol Methods. 2016;238:77-85. 27751949 10.1016/j.jviromet.2016.10.006 F1000 Recommendation
103. Brunker K Marston DA Horton DL : Elucidating the phylodynamics of endemic rabies virus in eastern Africa using whole-genome sequencing. Virus Evol. 2015;1(1):vev011. 27774283 10.1093/ve/vev011 5014479 F1000 Recommendation
104. Borucki MK Chen-Harris H Lao V : Ultra-deep sequencing of intra-host rabies virus populations during cross-species transmission. PLoS Negl Trop Dis. 2013;7(11):e2555. 24278493 10.1371/journal.pntd.0002555 3836733
105. Tarantola A Crabol Y Mahendra BJ : Caring for patients with rabies in developing countries - the neglected importance of palliative care. Trop Med Int Health. 2016;21(4):564-7. 26806229 10.1111/tmi.12670 F1000 Recommendation
106. Willoughby RE Jr : Rabies: Rare Human Infection - Common Questions. Infect Dis Clin North Am. 2015;29(4):637-50. 26384549 10.1016/j.idc.2015.07.006
107. Pathak S Horton DL Lucas S : Diagnosis, management and post-mortem findings of a human case of rabies imported into the United Kingdom from India: a case report. Virol J. 2014;11:63. 24708671 3977668
108. Xiang ZQ Greenberg L Ertl HC : Protection of non-human primates against rabies with an adenovirus recombinant vaccine. Virology. 2014;450-451:243-9. 24503087 10.1016/j.virol.2013.12.029 4038128
109. Huang CT Li Z Huang Y : Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Antiviral Res. 2014;110:132-41. 25108172 10.1016/j.antiviral.2014.07.013 4171353
110. Rodriguez JM Marchicio J López M : PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56 + (NK and NKT) cells. PLoS One. 2015;10(2):e0117484. 25706946 10.1371/journal.pone.0117484 4338301
111. Virojanapirom P Lumlertdacha B Wipattanakitchareon A : T-705 as a Potential Therapeutic Agent for Rabies. J Infect Dis. 2016;214(3):502-3. 27190188 10.1093/infdis/jiw174 F1000 Recommendation
112. Lingappa UF Wu X Macieik A : Host-rabies virus protein-protein interactions as druggable antiviral targets. Proc Natl Acad Sci U S A. 2013;110(10):E861-8. 23404707 10.1073/pnas.1210198110 3593902
113. Gnanadurai CW Fu ZF : CXCL10 and blood-brain barrier modulation in rabies virus infection. Oncotarget. 2016;7(10):10694-5. 26895109 10.18632/oncotarget.7428 4905431 F1000 Recommendation
114. Willoughby RE Opladen T Maier T : Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis. 2009;32(1):65-72. 18949578 10.1007/s10545-008-0949-z
115. Kammouni W Wood H Saleh A : Rabies virus phosphoprotein interacts with mitochondrial Complex I and induces mitochondrial dysfunction and oxidative stress. J Neurovirol. 2015;21(4):370-82. 25698500 10.1007/s13365-015-0320-8 F1000 Recommendation